Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IDEAS

Financiado

Cerrado

Improving Design Evaluation and Analysis of early drug development Studies

Drug development is a long and costly process which suffers from the major shortcoming that frequently failure is often only determined during the final stage. Recently, it has been recognised that more care needs to be taken duri... ver más

31/12/2018

Lancaster Universi...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

UNIVERSITY OF LANCASTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-12-31

MSCA-ITN-2014-ETN: Marie Skłodowska-Curie Innovative T... Scope:European Training Networks (ETN)

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

Lancaster University

819.86K€ | Lider

POLITO

516.12K€ | Participante

JANSSEN PHARMACEUTICA NV

250.56K€ | Participante

MEDIZINISCHE UNIVERSITAET WI...

511.87K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EATRIS The European Advanced Translational Research Infrastructure... 5M€ Cerrado

FutForm Future Formulations Developing Future Pharmaceuticals Throu... 414K€ Cerrado

CPCTAS CENTRE FOR PRE CLINICAL TESTING OF ACTIVE SUBSTANCES 1M€ Cerrado

PTQ-09-02-01379 Modelos farmacocinéticos y farmacodinámicos de predicción en... 28K€ Cerrado

SMART SMART Small Medicines Advanced Research Training 999K€ Cerrado

ConcePTION Building an ecosystem for better monitoring and communicatin... 29M€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2014-12-16
Fecha Fin: 2018-12-31

Líder del proyecto

UNIVERSITY OF LANCASTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Drug development is a long and costly process which suffers from the major shortcoming that frequently failure is often only determined during the final stage. Recently, it has been recognised that more care needs to be taken during the early stages of development to avoid going into lengthy and costly confirmatory studies with ineffective or harmful treatments. To achieve this goal it is essential to implement efficient methods for the design and analysis of such early development studies. The expertise in this area is, however, limited at the moment and adequate methodology is only partially available. Using a cross-sectorial, transnational approach, the IDEAS network brings together leading public and private sector researchers in the field with ample experience in training to educate, promote and support the future leaders in medical statistics in general and in the design and analysis of early developmental studies in particular. Within the network, cross-sectorial, transnational teams will support young researchers with individual methodological projects and devise an individually tailored training programme for them. Clinical advisors supplement the input of the supervisory team and ensure practical relevance and uptake of the methods devised. The training activities are comprised of a well-rounded mix of specialist, methodological components and generic, transferable skills. A mandatory set of networkwide training activities is supplemented by individual training components and cross-sectorial secondments, and particular attention is given to interaction and collaboration between researchers and supervisors across public and private sector partners. At the end of their training the researchers will be uniquely qualified with expertise in the field, benefit from experience in both public and private sector and can rely on a wide network of experts in the field in the future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores